SOUTH
SAN FRANCISCO, California and VANCOUVER, Canada, Nov. 10,
2022 /CNW/ - ESSA Pharma Inc. ("ESSA", or the
"Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company
focused on developing novel therapies for the treatment of prostate
cancer, today announced that the Company will be participating in
two upcoming investor conferences.
David. R. Parkinson, President and Chief Executive Officer of
ESSA Pharma, will participate in and host one-on-one meetings.
Peter Virsik, ESSA's Chief Operating
Officer, and David S. Wood, ESSA's
Chief Financial Officer, will also be participating in one-on-one
meetings
Presentation Details
Event: Jefferies London Healthcare Conference
Format: Fireside Chat
Date: Thursday, November 17,
2022
Time: 3:15 p.m. GMT /
10:15 a.m. ET
Event: Piper Sandler
34th Annual Healthcare Conference
Format: Fireside Chat
Date: Tuesday, November 29,
2022
Time: 4:30 p.m. ET
A live webcast of the Jefferies fireside chat can be accessed in
the Investors/Events & Presentations section of ESSA's website
at www.essapharma.com. Following the event, the webcast will be
archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on
developing novel and proprietary therapies for the treatment of
patients with prostate cancer. For more information, please visit
www.essapharma.com and follow us on Twitter under @ESSAPharma.
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-participate-in-two-upcoming-investor-conferences-301673393.html
SOURCE ESSA Pharma Inc